Eiko Lifesciences board meeting scheduled on May 26, 2026 to approve audited standalone and consolidated FY26 results.
Trading window closed since April 1, 2026 for designated persons until 48 hours after results declaration.
Disclosure made under SEBI Listing Regulations 29 and 33 for quarterly and annual financial results.